Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Su TH"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-5 z 5
    Tytuł:
    Paradigm shift in the treatment options of hepatocellular carcinoma.
    Autorzy:
    Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
    Hsu SJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital Yun-Lin Branch, Yunlin, Taiwan.
    Kao JH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
    Pokaż więcej
    Źródło:
    Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2022 Aug; Vol. 42 (9), pp. 2067-2079. Date of Electronic Publication: 2021 Sep 17.
    Typ publikacji:
    Journal Article; Review; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Carcinoma, Hepatocellular*/pathology
    Liver Neoplasms*/pathology
    Humans ; Immunotherapy ; Sorafenib/therapeutic use
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Acute-phase serum amyloid A for early detection of hepatocellular carcinoma in cirrhotic patients with low AFP level.
    Autorzy:
    Wu JL; Ph.D. Program for Cancer Biology and Drug Discovery, China Medical University and Academia Sinica, Taichung, Taiwan.; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
    Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
    Chen PJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
    Chen YR; Ph.D. Program for Cancer Biology and Drug Discovery, China Medical University and Academia Sinica, Taichung, Taiwan. .; Genomics Research Center, Academia Sinica, Taipei, Taiwan. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2022 Apr 06; Vol. 12 (1), pp. 5799. Date of Electronic Publication: 2022 Apr 06.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Carcinoma, Hepatocellular*/pathology
    Liver Neoplasms*/pathology
    Biomarkers ; Biomarkers, Tumor ; Humans ; Liver Cirrhosis/complications ; Liver Cirrhosis/diagnosis ; Prospective Studies ; ROC Curve ; Serum Amyloid A Protein ; alpha-Fetoproteins/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Hepatocellular carcinoma after treatment cessation in non-cirrhotic HBeAg-negative chronic hepatitis B: A multicentre cohort study.
    Autorzy:
    Papatheodoridi M; Department of Gastroenterology, National and Kapodistrian University of Athens School of Health Sciences, General Hospital of Athens 'Laiko', Athens, Greece.
    Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
    Hadziyannis E; 2nd Department of Internal Medicine, National and Kapodistrian University of Athens School of Health Sciences, General Hospital of Athens 'Hippokratio', Athens, Greece.
    Liao CH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
    Orfanidou Α; Department of Gastroenterology, National and Kapodistrian University of Athens School of Health Sciences, General Hospital of Athens 'Laiko', Athens, Greece.
    Yang HC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
    Zachou K; Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center in Autoimmune Liver Diseases, General University Hospital of Larissa, Larissa, Greece.
    Liu CJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
    Kourikou A; 2nd Department of Internal Medicine, National and Kapodistrian University of Athens School of Health Sciences, General Hospital of Athens 'Hippokratio', Athens, Greece.
    Gatselis N; Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center in Autoimmune Liver Diseases, General University Hospital of Larissa, Larissa, Greece.
    Manolakopoulos S; Department of Gastroenterology, National and Kapodistrian University of Athens School of Health Sciences, General Hospital of Athens 'Laiko', Athens, Greece.; 2nd Department of Internal Medicine, National and Kapodistrian University of Athens School of Health Sciences, General Hospital of Athens 'Hippokratio', Athens, Greece.
    Dalekos G; Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center in Autoimmune Liver Diseases, General University Hospital of Larissa, Larissa, Greece.
    Kao JH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
    Hadziyannis S; 2nd Department of Internal Medicine, National and Kapodistrian University of Athens School of Health Sciences, General Hospital of Athens 'Hippokratio', Athens, Greece.
    Papatheodoridis GV; Department of Gastroenterology, National and Kapodistrian University of Athens School of Health Sciences, General Hospital of Athens 'Laiko', Athens, Greece.
    Pokaż więcej
    Źródło:
    Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2022 Mar; Vol. 42 (3), pp. 541-550. Date of Electronic Publication: 2021 Dec 20.
    Typ publikacji:
    Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Carcinoma, Hepatocellular*/pathology
    Hepatitis B, Chronic*/complications
    Hepatitis B, Chronic*/drug therapy
    Liver Neoplasms*/pathology
    Antiviral Agents ; Cohort Studies ; Hepatitis B e Antigens ; Hepatitis B virus ; Humans ; Neoplasm Recurrence, Local ; Withholding Treatment
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Response to Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.
    Autorzy:
    Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
    Kao JH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
    Pokaż więcej
    Źródło:
    Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2017 Feb; Vol. 37 (2), pp. 310-311.
    Typ publikacji:
    Letter; Research Support, Non-U.S. Gov't; Comment
    MeSH Terms:
    Carcinoma, Hepatocellular*
    Hepatitis B, Chronic*
    Antiviral Agents ; DNA, Viral ; Guanine/analogs & derivatives ; Hepatitis B virus/genetics ; Humans ; Liver Cirrhosis ; Liver Neoplasms
    Raport
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.
    Autorzy:
    Su TH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
    Hu TH; Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
    Chen CY; Department of Internal Medicine, Chia-Yi Christian Hospital, Chiayi, Taiwan.
    Huang YH; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.
    Chuang WL; Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
    Lin CC; Division of Gastroenterology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.
    Wang CC; Division of Gastroenterology, Department of Internal Medicine, Taipei Tzuchi Hospital, the Buddhist Tzuchi Medical Foundation, Taipei, Taiwan.
    Su WW; Department of Gastroenterology and Hepatology, Changhua Christian Hospital, Changhua, Taiwan.
    Chen MY; Department of Internal Medicine, Shuang-Ho Hospital, Taipei Medical University, Taipei, Taiwan.
    Peng CY; Division of Hepatogastroenterology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
    Chien RN; Liver Research Unit, Chang Gung Memorial Hospital, Keelung, Taiwan.
    Huang YW; Liver Center, Cathay General Hospital Medical Center, Taipei, Taiwan.
    Wang HY; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan.
    Lin CL; Department of Gastroenterology, Ren-Ai Branch, Taipei City Hospital, Taipei, Taiwan.
    Yang SS; Division of Gastroenterology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
    Chen TM; Division of Hepato-Gastroenterology, Department of Internal Medicine and Department of Medical Research, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan.
    Mo LR; Department of Internal Medicine, Tainan Municipal Hospital, Tainan, Taiwan.
    Hsu SJ; Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Yunlin, Taiwan.
    Tseng KC; Department of Hepatology, Buddhist Tzu Chi General Hospital, Da-Lin Branch, Chiayi, Taiwan.
    Hsieh TY; Department of Gastroenterology, Tri-service General Hospital, Taipei, Taiwan.
    Suk FM; Division of Gastroenterology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
    Hu CT; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Buddhist Tzu Chi General Hospital and University, Hualien, Taiwan.
    Bair MJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mackay Memorial Hospital, Taitung, Taiwan.
    Liang CC; Department of Internal Medicine, Far Eastern Memorial Hospital, Taipei, Taiwan.
    Lei YC; Department of Family Medicine, National Taiwan University Hospital, Taipei, Taiwan.
    Tseng TC; Department of Internal Medicine, National Taiwan University Hospital, Jin-Shan Branch, New Taipei City, Taiwan.
    Chen CL; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
    Kao JH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
    Pokaż więcej
    Corporate Authors:
    C-TEAM study group and the Taiwan Liver Diseases Consortium
    Źródło:
    Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2016 Dec; Vol. 36 (12), pp. 1755-1764. Date of Electronic Publication: 2016 Oct 04.
    Typ publikacji:
    Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Antiviral Agents/*therapeutic use
    Carcinoma, Hepatocellular/*epidemiology
    Guanine/*analogs & derivatives
    Hepatitis B, Chronic/*complications
    Hepatitis B, Chronic/*drug therapy
    Liver Cirrhosis/*mortality
    Liver Neoplasms/*epidemiology
    Adult ; Esophageal and Gastric Varices/epidemiology ; Female ; Gastrointestinal Hemorrhage/epidemiology ; Guanine/therapeutic use ; Hepatitis B e Antigens/blood ; Hepatitis B virus/genetics ; Humans ; Male ; Middle Aged ; Multivariate Analysis ; Proportional Hazards Models ; Prospective Studies ; Retrospective Studies ; Taiwan ; Treatment Outcome ; alpha-Fetoproteins/analysis
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-5 z 5

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies